Clinical Trial Update: The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating zoledronic acid to prevent cancer-treatment–induced bone loss in postmenopausal women with breast cancer on adjuvant letrozole; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-04-11